The main topic of the report concerns the economic overview and market updates in the life sciences sector for 2025-2026.
Key findings include an optimistic financial outlook for the life sciences industry, but with expectations of volatility due to changes in the US administration, global regulatory changes, and geopolitical uncertainty. The impact of trade wars, tariffs, and policy changes on market participants' confidence is also highlighted. There is an increase in mergers and acquisitions (M&A) activity and capital markets in 2024, with further growth expected in 2025. The medical devices market is undergoing transformation due to technological advancements and regulatory updates.